Weight loss

Beyond Weight Loss: Reading the GLP-1 Side Effect Profile in Real Numbers A field guide for clinicians who are tired of being shown hazard ratios without denominators.

Volume 1 - Issue 3 (May 2026

The 2026 IDSA AMR Guidance: What Changed, Why It Changed, and What You Do Monday Morning

The Contrast Nephropathy That Wasn't

Staphylococcus aureus Bacteremia in 2026: A New Guideline, a Landmark Trial, and What It Means at the Bedside

Does glucosamine accelerate Alzheimer’s? A big claim, a small denominator

PharmaCompass InPHARMation is for educational purposes only and does not constitute medical advice. Always verify clinical information before applying to patient care. Full Disclaimer | © 2026 PharmaCompass Education, LLC

Read more

The 2026 IDSA AMR Guidance: What Changed, Why It Changed, and What You Do Monday Morning

The Contrast Nephropathy That Wasn't

Staphylococcus aureus Bacteremia in 2026: A New Guideline, a Landmark Trial, and What It Means at the Bedside

Does glucosamine accelerate Alzheimer’s? A big claim, a small denominator